BILLEV PHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 81814813
Slotsmarken 10, 2970 Hørsholm
billev@billevpharma.dk
tel: 47522600
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 21 427.86 | 25 637.71 | 30 170.80 | 29 072.53 | 24 763.23 |
| Costs of management | -16 532.65 | -18 517.89 | -22 409.46 | -22 678.60 | -20 406.56 |
| EBIT | 4 895.21 | 7 119.82 | 7 761.34 | 6 393.93 | 4 356.67 |
| Other financial income | 1.61 | 28.30 | 22.20 | 13.86 | 25.86 |
| Other financial expenses | -34.54 | -27.91 | -62.92 | -65.79 | -40.52 |
| Pre-tax profit | 4 862.28 | 7 120.21 | 7 720.62 | 6 342.00 | 4 342.02 |
| Income taxes | -1 075.57 | -1 571.35 | -1 707.46 | -1 398.95 | - 963.48 |
| Net earnings | 3 786.71 | 5 548.86 | 6 013.16 | 4 943.06 | 3 378.54 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 26.94 | 13.84 | 5.52 | 2.87 | 14.81 |
| Tangible assets total | 26.94 | 13.84 | 5.52 | 2.87 | 14.81 |
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 2 215.57 | 6 467.15 | 4 741.90 | 4 308.44 | 3 900.89 |
| Prepayments and accrued income | 311.81 | 441.89 | 524.18 | 397.75 | 337.90 |
| Current other receivables | 236.52 | 201.46 | 201.08 | 204.09 | 295.07 |
| Short term receivables total | 2 763.90 | 7 110.50 | 5 467.16 | 4 910.28 | 4 533.86 |
| Other current investments | 134.09 | 159.60 | 161.89 | 163.02 | 174.87 |
| Cash and bank deposits | 5 139.71 | 2 082.48 | 4 726.96 | 3 870.32 | 2 187.41 |
| Cash and cash equivalents | 5 273.80 | 2 242.07 | 4 888.86 | 4 033.34 | 2 362.28 |
| Balance sheet total (assets) | 8 064.65 | 9 366.41 | 10 361.53 | 8 946.50 | 6 910.95 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 320.00 | 320.00 | 320.00 | 320.00 | 320.00 |
| Shares repurchased | 3 786.71 | 5 548.86 | 6 013.16 | 4 943.06 | 3 378.54 |
| Retained earnings | -3 786.71 | -5 548.86 | -6 013.16 | -4 943.06 | -3 378.54 |
| Profit of the financial year | 3 786.71 | 5 548.86 | 6 013.16 | 4 943.06 | 3 378.54 |
| Shareholders equity total | 4 106.71 | 5 868.86 | 6 333.16 | 5 263.06 | 3 698.54 |
| Provisions | 70.95 | 100.26 | 116.53 | 88.14 | 73.82 |
| Non-current deferred tax liabilities | 624.04 | 346.62 | 1 450.86 | 1 361.72 | 606.74 |
| Non-current liabilities total | 624.04 | 346.62 | 1 450.86 | 1 361.72 | 606.74 |
| Current trade creditors | 149.98 | 130.25 | 244.16 | 161.00 | 476.60 |
| Short-term deferred tax liabilities | 240.90 | 15.76 | |||
| Other non-interest bearing current liabilities | 2 872.07 | 2 920.43 | 2 216.82 | 2 056.82 | 2 055.25 |
| Current liabilities total | 3 262.94 | 3 050.68 | 2 460.98 | 2 233.58 | 2 531.85 |
| Balance sheet total (liabilities) | 8 064.65 | 9 366.41 | 10 361.53 | 8 946.50 | 6 910.95 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.